MAZZAROTTO, RENZO
 Distribuzione geografica
Continente #
NA - Nord America 382
EU - Europa 339
AS - Asia 106
AF - Africa 1
OC - Oceania 1
Totale 829
Nazione #
US - Stati Uniti d'America 381
CN - Cina 97
SE - Svezia 76
GB - Regno Unito 60
IT - Italia 59
IE - Irlanda 54
FR - Francia 46
BE - Belgio 16
DE - Germania 14
VN - Vietnam 6
UA - Ucraina 5
RU - Federazione Russa 4
FI - Finlandia 2
AU - Australia 1
CA - Canada 1
CH - Svizzera 1
IR - Iran 1
KZ - Kazakistan 1
MK - Macedonia 1
NG - Nigeria 1
NL - Olanda 1
TH - Thailandia 1
Totale 829
Città #
Chandler 158
Southend 59
Dublin 54
Jacksonville 21
Redmond 20
Lawrence 18
Princeton 18
Beijing 17
Brussels 16
Wilmington 16
Ann Arbor 14
Ashburn 14
Jinan 13
Houston 12
Nanjing 12
Verona 12
Redwood City 8
Haikou 7
Ningbo 7
Tianjin 6
Bologna 5
Dearborn 5
Falls Church 5
Hebei 5
Taizhou 5
Lozzo Atestino 4
Woodbridge 4
Hangzhou 3
Shenyang 3
Zhengzhou 3
Caneva 2
Dong Ket 2
Fuzhou 2
Milan 2
Norwalk 2
Phoenix 2
Rome 2
Abuja 1
Almaty 1
Cembra 1
Changsha 1
Chaoyang 1
Clearwater 1
Dallas 1
Des Moines 1
Düsseldorf 1
Fairfield 1
Falkenstein 1
Geneve 1
Groningen 1
Guangzhou 1
Hefei 1
Hongtong 1
Jiaxing 1
Lanzhou 1
London 1
Nanchang 1
Nettuno 1
Oklahoma City 1
San Francisco 1
Shanghai 1
Skopje 1
Sydney 1
Toronto 1
Torreglia 1
Vetralla 1
Yuanping 1
Zanjan 1
Totale 589
Nome #
Diffuse gliomas in patients aged 55 years or over: A suggestion for IDH mutation testing 77
Analisi di sopravvivenza ed esiti nei pazienti pediatrici con tumore cerebrale in età pediatirca trattati presso il centro di oncoematologia pediatrica di Verona dal 1999 al 2017 72
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer 67
A Dirichlet process mixture model for automatic (18)F-FDG PET image segmentation: Validation study on phantoms and on lung and esophageal lesions 64
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 56
Analisi radiomica delle modificazioni dopo radioterapia neoadiuvante in pazienti con adenocarcinoma del pancreas 51
Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma 50
Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer 50
Predictive role of changes in the tumor burden and International Metastatic Renal Cell Carcinoma Database Consortium class during active surveillance for metastatic renal cell carcinoma 47
Molecular predictors of EGFR-mutant NSCLC transformation into LCNEC after frontline osimertinib: digging under the surface 47
Can CT texture analysis predict resectability and surgical outcomes after neoadjuvant radiotherapy in pancreatic cancer patients? 44
Corrigendum: Melanoma of Unknown Primary: Evaluation of the Characteristics, Treatment Strategies, Prognostic Factors in a Monocentric Retrospective Study 43
A Therapeutic and Diagnostic Multidisciplinary Pathway for Merkel Cell Carcinoma Patients 38
Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to Raise the Bar 35
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma 34
Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease 33
18F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy 31
Long-Term Outcomes of Induction Chemotherapy Followed by Chemo-Radiotherapy as Intensive Neoadjuvant Protocol in Patients with Esophageal Cancer 27
Totale 866
Categoria #
all - tutte 2155
article - articoli 1923
book - libri 0
conference - conferenze 232
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4310


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201945 15156 24 92 0001
2019/202080 6005 1017 72 461013
2020/2021151 218214 1210 917 521239
2021/2022164 1542115 134 57 531440
2022/2023405 26593578 25109 321 40270
Totale 866